ENXTPA:DSYSoftware
Assessing Dassault Systèmes' (ENXTPA:DSY) Valuation After Medidata's New Oncology AI And Clinical Trial Results
Dassault Systèmes (ENXTPA:DSY) is in focus after its Medidata unit used the ASCO 2026 meeting to showcase new oncology research and upgraded AI imaging tools for clinical trials, highlighting its exposure to life sciences.
See our latest analysis for Dassault Systèmes.
The recent ASCO announcements come after a weak year-to-date share price return, with the stock down 19.64%, and a 1-year total shareholder return that declined 42.25%. This suggests sentiment has softened despite Medidata’s...